featured
Selonsertib for Patients With Bridging Fibrosis or Compensated Cirrhosis Due to NASH
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Selonsertib for Patients With Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results From Randomized Phase III STELLAR Trials
J. Hepatol. 2020 Jul 01;73(1)26-39, SA Harrison, VW Wong, T Okanoue, N Bzowej, R Vuppalanchi, Z Younes, A Kohli, S Sarin, SH Caldwell, N Alkhouri, ML Shiffman, M Camargo, G Li, K Kersey, C Jia, Y Zhu, CS Djedjos, GM Subramanian, RP Myers, N Gunn, A Sheikh, QM Anstee, M Romero-Gomez, M Trauner, Z Goodman, EJ Lawitz, Z YounossiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.